Detalhe da pesquisa
1.
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy.
Cancer
; 130(8): 1270-1280, 2024 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38153814
2.
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort.
Am J Hematol
; 99(2): 254-262, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38108611
3.
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome.
Cancer
; 129(11): 1704-1713, 2023 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36932983
4.
Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML.
Cancer
; 129(17): 2637-2644, 2023 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37354090
5.
Assessing gene function in human B cells: CRISPR/Cas9-based gene editing and mRNA-based gene expression in healthy and tumor cells.
Eur J Immunol
; 52(8): 1362-1365, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35527391
6.
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi.
Hematol Oncol
; 41(1): 78-87, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36177902
7.
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort.
Hematol Oncol
; 41(1): 128-138, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36265128
8.
Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the "RTL" (regional Tuscan lymphoma network).
Ann Hematol
; 102(4): 841-849, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36735074
9.
Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials.
Ann Hematol
; 102(6): 1375-1382, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-37079069
10.
Long-term efficacy in patients with relapsed/refractory diffuse large B-cell lymphoma achieving a complete response with pixantrone.
Eur J Haematol
; 111(2): 247-253, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37161912
11.
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis.
Cancer
; 128(13): 2449-2454, 2022 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35363892
12.
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study.
Br J Haematol
; 199(1): 54-60, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35906881
13.
COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report.
Br J Haematol
; 196(3): 559-565, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34636033
14.
Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study.
Blood
; 135(8): 534-541, 2020 02 20.
Artigo
Inglês
| MEDLINE | ID: mdl-31877211
15.
Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study.
Haematologica
; 107(10): 2356-2364, 2022 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35385922
16.
The safety and clinical effectiveness of rapid infusion with CT-P10 in patients with non-Hodgkin's lymphoma or chronic lymphocytic leukemia: A retrospective non-interventional post-authorization safety study in Europe.
Hematol Oncol
; 40(3): 370-380, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35168291
17.
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV.
Hematol Oncol
; 40(5): 846-856, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-35854643
18.
Pixantrone in patients with relapsed/refractory diffuse large B-cell lymphoma: A real-life, retrospective, multicenter trial on behalf of the "RTL" (Regional Tuscan Lymphoma network).
Eur J Haematol
; 108(5): 383-390, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-35051301
19.
Carfilzomib plus dexamethasone in patients with relapsed and refractory multiple myeloma: A retro-prospective observational study.
Eur J Haematol
; 109(4): 373-380, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-35749094
20.
Monoclonal gammopathy of renal significance (MGRS): Real-world data on outcomes and prognostic factors.
Am J Hematol
; 97(7): 877-884, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35389534